Thrombolytics for acute ischemic stroke: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
== | {| border="1" cellspacing="1" cellpadding="1" style="width: 500px; " | ||
|- | |||
| Table Test | |||
| Table Test | |||
|- | |||
| <br/> | |||
| <br/> | |||
|- | |||
| <br/> | |||
| <br/> | |||
|} | |||
== <br/> == | |||
== Background == | |||
#Pros: | |||
# | ##30% greater chance of good neurologic outcome at 3 months | ||
# | ##Comparable 3-month mortality rate | ||
# | #Cons | ||
##Intracranial hemorrhage occurs in ~5% of pts | |||
===ECASS III Exclusion Criteria (if giving tPA between 3-4.5 hours)=== | *Coag results prior to tx is only required for pts on anticoagulants | ||
*...but if history unable to be obtained must wait for coag results prior to starting tx | |||
== Inclusion Criteria == | |||
#Diagnosis of ischemic stroke causing measurable neuro deficit | |||
#Clear onset (last witnessed well) <3 hours (see below for extension to <4.5 hours) | |||
#Age >18 yrs | |||
== Exclusion Criteria == | |||
=== Absolute === | |||
#Head trauma or prior stroke in previous 3 months | |||
#Symptoms suggestive of SAH | |||
#Arterial puncture at noncompressible site in previous 7 days | |||
#History of previous ICH | |||
#Elevated BP (sys > 185 or dia > 110 | |||
#Active bleeding on exam | |||
#Acute bleeding diathesis: | |||
##Plt count < 100K | |||
##PTT > upper limit of normal | |||
##INR >1.7 | |||
#Blood Glucose <50 | |||
#CT demonstrates multilobar infarction (hypodensity > 1/3 cerebral hemisphere) | |||
=== Relative === | |||
#Minor stroke or rapidly improving stroke symptoms | |||
#Seizure at onset with postictal residual neuro impairments | |||
#Major surgery or serious trauma within previous 14 days | |||
#Acute GI or GU hemorrhage (within previous 21 days) | |||
#Acute MI (within previous 3 months) | |||
=== ECASS III Exclusion Criteria (if giving tPA between 3-4.5 hours) === | |||
#Age > 80 | #Age > 80 | ||
#Baseline NIHSS > 25 | #Baseline NIHSS > 25 | ||
| Line 43: | Line 64: | ||
#History of prior stroke and DM | #History of prior stroke and DM | ||
==Studies Needed== | == Studies Needed == | ||
# Head CT | |||
# CBC | #Head CT | ||
# PT/PTT | #CBC | ||
# Glu check | #PT/PTT | ||
# ECG | #Glu check | ||
# Icon | #ECG | ||
#Icon | |||
== tPA Administration == | |||
#Alteplase 0.9mg/kg IV (max 90mg total) | |||
# Alteplase 0.9mg/kg IV (max 90mg total) | ##Load with .09mg/kg (10% of dose) as IV bolus over 1min, followed by 0.81mg/kg (90% of dose) as cont. infusion over 60min | ||
## Load with .09mg/kg (10% of dose) as IV bolus over 1min, followed by 0.81mg/kg (90% of dose) as cont. infusion over 60min | #Neuo check Q15min x 2hrs, Q30min x6hrs, Q1hr x 16hrs | ||
# Neuo check Q15min x 2hrs, Q30min x6hrs, Q1hr x 16hrs | #Keep BP <180/105 | ||
# Keep BP <180/105 | ##Labetalol 10mg IV followed by continous IV infusion 2-8mg/min OR | ||
## Labetalol 10mg IV followed by continous IV infusion 2-8mg/min OR | ##Nicardipine IV 5mg/h, titrate up to desired effect by 2.5mg/hr q 5-15min, maximum 15mg/h | ||
## Nicardipine IV 5mg/h, titrate up to desired effect by 2.5mg/hr q 5-15min, maximum 15mg/h | ##If BP not controlled or dia > 140 consider nitroprusside | ||
## If BP not controlled or dia > 140 consider nitroprusside | #No anticoatulation/antiplatelets x 24hrs | ||
# No anticoatulation/antiplatelets x 24hrs | #Stop tPA and consider head CT if pt develops: | ||
# Stop tPA and consider head CT if pt develops: | ##Neuro changes | ||
## Neuro changes | ##Acute hypertension | ||
## Acute hypertension | ##Nausea/vomiting | ||
## Nausea/vomiting | |||
== See Also == | |||
[[Post-tPA Hemorrhage]] | [[Post-tPA Hemorrhage]] | ||
==Source== | == Source == | ||
1/26/06 DONALDSON (adapted from Lampe, Tintinali) | 1/26/06 DONALDSON (adapted from Lampe, Tintinali) | ||
| Line 75: | Line 100: | ||
AHA/ASA Guidelines | AHA/ASA Guidelines | ||
[[Category:Neuro]] | <br/>[[Category:Neuro]] <br/>[[Category:Procedures]] <br/><br/><br/> | ||
[[Category:Procedures]] | |||
Revision as of 16:16, 26 June 2011
| Table Test | Table Test |
Background
- Pros:
- 30% greater chance of good neurologic outcome at 3 months
- Comparable 3-month mortality rate
- Cons
- Intracranial hemorrhage occurs in ~5% of pts
- Coag results prior to tx is only required for pts on anticoagulants
- ...but if history unable to be obtained must wait for coag results prior to starting tx
Inclusion Criteria
- Diagnosis of ischemic stroke causing measurable neuro deficit
- Clear onset (last witnessed well) <3 hours (see below for extension to <4.5 hours)
- Age >18 yrs
Exclusion Criteria
Absolute
- Head trauma or prior stroke in previous 3 months
- Symptoms suggestive of SAH
- Arterial puncture at noncompressible site in previous 7 days
- History of previous ICH
- Elevated BP (sys > 185 or dia > 110
- Active bleeding on exam
- Acute bleeding diathesis:
- Plt count < 100K
- PTT > upper limit of normal
- INR >1.7
- Blood Glucose <50
- CT demonstrates multilobar infarction (hypodensity > 1/3 cerebral hemisphere)
Relative
- Minor stroke or rapidly improving stroke symptoms
- Seizure at onset with postictal residual neuro impairments
- Major surgery or serious trauma within previous 14 days
- Acute GI or GU hemorrhage (within previous 21 days)
- Acute MI (within previous 3 months)
ECASS III Exclusion Criteria (if giving tPA between 3-4.5 hours)
- Age > 80
- Baseline NIHSS > 25
- Any oral anticoagulant use
- History of prior stroke and DM
Studies Needed
- Head CT
- CBC
- PT/PTT
- Glu check
- ECG
- Icon
tPA Administration
- Alteplase 0.9mg/kg IV (max 90mg total)
- Load with .09mg/kg (10% of dose) as IV bolus over 1min, followed by 0.81mg/kg (90% of dose) as cont. infusion over 60min
- Neuo check Q15min x 2hrs, Q30min x6hrs, Q1hr x 16hrs
- Keep BP <180/105
- Labetalol 10mg IV followed by continous IV infusion 2-8mg/min OR
- Nicardipine IV 5mg/h, titrate up to desired effect by 2.5mg/hr q 5-15min, maximum 15mg/h
- If BP not controlled or dia > 140 consider nitroprusside
- No anticoatulation/antiplatelets x 24hrs
- Stop tPA and consider head CT if pt develops:
- Neuro changes
- Acute hypertension
- Nausea/vomiting
See Also
Source
1/26/06 DONALDSON (adapted from Lampe, Tintinali)
2/20/10 PANI (ACEP/AAN Guidelines--class B recommendations)
AHA/ASA Guidelines
